Effect of omega 3 in Parkinson disease.
Phase 3
- Conditions
- parkinson.
- Registration Number
- IRCT20100123003140N21
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Those who have Parkinson's diagnosis by a neurologist
Those aged 50-70
People who do not use aspirin or another anticoagulant, or statin
Exclusion Criteria
Unwillingness to cooperate
Patients who already took Omega-3 (6 months ago)
Patients who have depression or psychosis or have another inflammatory disease
Patients who are unable to take supplementation due to digestive problems or allergic reactions
Patients who smoke and drink alcohol
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of IL-1B. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of IL-6. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of TNF-a. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of IL-10. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of TG. Timepoint: The beginning and the end of the study. Method of measurement: LBL KIT.;Serum levels of HDL. Timepoint: The beginning and the end of the study. Method of measurement: LBL KIT.;Serum levels of LDL. Timepoint: The beginning and the end of the study. Method of measurement: By the formula.
- Secondary Outcome Measures
Name Time Method Check for food. Timepoint: At first and during the study. Method of measurement: A 24-hour recall questionnaire and MNA questionnaire MNA.;Physical activity review. Timepoint: At the beginig of the study. Method of measurement: RAPA questionnaire.;Anthropometric Indicators. Timepoint: The beginning and the end of the study. Method of measurement: Impedance bi-electric system.;BMI. Timepoint: The beginning and the end of the study. Method of measurement: By the formula.;Serum Alb level. Timepoint: Beginning of study. Method of measurement: Enzymatic.